ClinConnect ClinConnect Logo
Search / Trial NCT06465758

Prognostic Recovery Observations and Guidance for Evaluating Stroke Survivors

Launched by IRCCS SAN RAFFAELE · Jun 13, 2024

Trial Information

Current as of August 22, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how to better understand and predict how people recover after experiencing a stroke. Researchers are looking at different factors that might influence recovery, such as how well someone can move or perform daily activities following a stroke. By identifying patterns and important outcomes, the goal is to help doctors provide better guidance and support to stroke survivors and their families.

To be eligible for the trial, participants need to be at least 18 years old and have had a confirmed stroke, either from bleeding in the brain or a blockage. They should be within 3 to 10 days after the stroke and have some level of difficulty on a specific test measuring their condition. However, individuals who have had a temporary stroke-like event or major complications from other health issues may not be included. Participants can expect to undergo assessments that will help researchers learn more about recovery patterns. Overall, this trial aims to enhance understanding of post-stroke recovery to improve outcomes for patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age ≥ 18
  • Haemorrhagic or ischaemic stroke confirmed by a clinical diagnosis and by brain imaging
  • NIHSS item 5-6 ≥1
  • 3 to 10 days post-stroke
  • Exclusion Criteria:
  • Transient ischaemic attack
  • Premorbid Modified Rankin Scale ≥ 4
  • Acute orthopaedic complications
  • Inability to give informed consent

About Irccs San Raffaele

IRCCS San Raffaele is a prestigious research hospital and clinical trial sponsor based in Milan, Italy, renowned for its commitment to advancing medical science through innovative research and high-quality patient care. As an Institute for Research and Healthcare, it specializes in a wide range of therapeutic areas, including oncology, neurology, and cardiology, and is dedicated to translating scientific discoveries into effective clinical practices. With a multidisciplinary team of experts and state-of-the-art facilities, IRCCS San Raffaele plays a pivotal role in conducting rigorous clinical trials that contribute to the development of novel treatments and improve patient outcomes globally.

Locations

Milano, , Italy

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported